Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
Silo Pharma (NASDAQ: SILO) announced on October 8, 2025 its initial purchase of Bitcoin as part of a crypto reserve strategy aimed at multi-chain asset growth. The company said this purchase complements earlier crypto buys in Ethereum, RSC, and Solano tokens and signals conviction in Bitcoin as a store of value and a hedge against market volatility. Management indicated Silo will continue building a diversified digital-asset treasury to support the company’s multi-chain growth approach.
Silo Pharma (NASDAQ: SILO) ha annunciato il 8 ottobre 2025 il suo primo acquisto di Bitcoin nell'ambito di una strategia di riserva crypto mirata a crescita di asset multi-chain. L'azienda ha detto che questo acquisto integra gli acquisti crypto precedenti in Ethereum, RSC e token Solano e segnala fiducia in Bitcoin come riserva di valore e copertura contro la volatilità del mercato. Il management ha indicato che Silo continuerà a costruire una tesoreria digitale diversificata per supportare l'approccio di crescita multi-chain dell'azienda.
Silo Pharma (NASDAQ: SILO) anunció el 8 de octubre de 2025 su compra inicial de Bitcoin como parte de una estrategia de reserva de criptoactivos destinada al crecimiento de activos en múltiples cadenas. La empresa dijo que esta compra complementa compras anteriores de cripto en Ethereum, RSC y tokens Solano y señala convicción en Bitcoin como reserva de valor y cobertura frente a la volatilidad del mercado. La dirección indicó que Silo seguirá construyendo una tesorería digital diversificada para apoyar el enfoque de crecimiento multineta de la compañía.
Silo Pharma (NASDAQ: SILO)는 2025년 10월 8일을 시작으로 암호화폐 보유 전략의 일환으로 비트코인을 최초로 매수했다고 발표했습니다. 이 전략은 다중 체인 자산 성장을 목표로 합니다. 회사는 이번 매수가 이더리움, RSC, 솔라노 토큰에 대한 기존 암호화 자매 매수들을 보완하며 비트코인을 가치 저장 수단이자 시장 변동성에 대한 헤지로 보는 확신을 시사한다고 밝혔습니다. 경영진은 실질적으로 다중 체인 성장 접근 방식을 지원하기 위해 다각화된 디지털 자산 보유고를 계속 구축할 것이라고 언급했습니다.
Silo Pharma (NASDAQ : SILO) a annoncé le 8 octobre 2025 son achat initial de Bitcoin dans le cadre d'une stratégie de réserve crypto visant la croissance d'actifs multi-chaînes. L'entreprise a déclaré que cet achat complète des acquisitions cryptographiques antérieures en Ethereum, RSC et jetons Solano et témoigne d'une conviction envers Bitcoin en tant que réserve de valeur et couverture contre la volatilité du marché. La direction a indiqué que Silo continuera à constituer une trésorerie numérique diversifiée pour soutenir l'approche de croissance multi-chaînes de l'entreprise.
Silo Pharma (NASDAQ: SILO) kündigte am 8. Oktober 2025 seinen Erstkauf von Bitcoin im Rahmen einer Krypto-Reserven-Strategie an, die auf Multi-Chain-Asset-Wachstum abzielt. Das Unternehmen sagte, dieser Kauf ergänze frühere Käufe von Kryptowährungen in Ethereum, RSC und Solano-Tokens und zeige Überzeugung in Bitcoin als Wertaufbewahrung und Absicherung gegen Marktvolatilität. Das Management gab an, dass Silo weiterhin eine diversifizierte Digital-Asset-Treasury aufbauen wird, um den Multi-Chain-Wachstumsansatz des Unternehmens zu unterstützen.
Silo Pharma (NASDAQ: SILO) أعلنت في 8 أكتوبر 2025 عن أول عملية شراء للبيتكوين كجزء من استراتيجية احتياطيّة للعملة المشفّرة تهدف إلى نمو الأصول عبر سلاسل متعددة. قالت الشركة إن هذه الصفقة تكمل مشتريات العملات المشفرة السابقة في إيثريوم و RSC ورموز Solano وتدل على اقتناع بالبيتكوين كخزينة قيمة وتحصين من تقلبات السوق. وأشار المدراء إلى أن Silo ستواصل بناء treasury رقمية متنوعة لدعم نهج الشركة للنمو عبر سلاسل متعددة.
Silo Pharma (NASDAQ: SILO) 宣布在 2025年10月8日 开展其首次购买比特币，作为面向多链资产增长的加密储备战略的一部分。公司表示此次购买是对早前在以太坊、RSC 和 Solano 代币的加密资产购置的补充，并传达了对比特币作为价值储存和对冲市场波动的信心。管理层表示，Silo 将继续构建多元化的数字资产金库，以支持公司多链增长策略。
- None.
- None.
SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of Bitcoin under its crypto reserve strategy targeting multi-chain asset growth.
“Silo’s latest strategic crypto purchase signals our conviction in Bitcoin as both store of value and a hedge against general financial market volatility,” said Eric Weisblum, CEO of Silo. “Overall, the four crypto investments we have made so far underscore our Company’s confidence in the growing adoption and value creation opportunities available through a digital asset treasury portfolio.”
Silo’s initial purchase of Bitcoin follows recently announced crypto purchases of Ethereum, RSC, and Solano tokens. The Company plans to continue purchasing various crypto tokens as part of its diversified treasury reserve strategy.
About Silo Pharma
Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. Its therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories. silopharma.com
Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified using words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential”, and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that could cause the actual results of Silo Pharma, Inc. (“Silo” or “the Company”) to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this press release, whether as a result of new information, future events, or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events except as required by law.
Contact
800-705-0120
investors@silopharma.com
FAQ
What did Silo Pharma (SILO) announce on October 8, 2025 regarding Bitcoin?
Which cryptocurrencies has Silo Pharma (SILO) already purchased for its treasury?
How does Silo Pharma describe Bitcoin's role in its treasury strategy (SILO)?
Will Silo Pharma (SILO) continue buying crypto for its treasury and when was that stated?
What does Silo Pharma's (SILO) crypto treasury move mean for investors?
